In order to assess whether the adrenocortical carcinoma samples express GNRHR, LHCGR and FSH expression was studied using a commercial in situ hybridization RNAscope kit with single transcript resolution (Wang et al. 2012). Here, BRD2 is linked to adrenal cortex carcinoma.